What we do
COVID-19 in the Netherlands
RIVMNational Institute for Public Health and the Environment advises the Dutch government on how to control the coronavirus as effectively as possible, monitors the COVID-19 outbreak and conducts research into SARS-CoV-2. RIVM is coordinating the implementation of the COVID-19 vaccinations in the Netherlands. Our institute is responsible for coordinating the storage and distribution of COVID-19 vaccines in the Netherlands (including the islands of Aruba, Bonaire, St Eustatius, Saba, Curaçao and St Maarten).
We provide weekly updates and data on COVID-19 in the Netherlands. In addition to our general COVID-19 weekly epidemiological update, we also publish a COVID-19 weekly update for the CAS and BES islands: the islands of Curaçao, Aruba and Sint Maarten and the special municipalities Bonaire, Sint Eustatius and Saba.
Vaccination reduces transmission to unvaccinated household members by 63% for Delta variant
Vaccination protects against COVID-19, and also reduces the risk of transmitting the virus to others.
4 in 5 COVID-19 patients in ICU are not vaccinated
4 in 5 COVID-19 patients in intensive care are not vaccinated against the coronavirus SARS-CoV-2.
Expected autumn increase in SARS-CoV-2 appears to have started
In the past week from 5-12 October 2021, the reported number of people who tested positive for COVID-19 increased by 48% compared to the previous week. Reported figures increased in all regions and in all age groups.
More than health risks play a role in compliance with coronavirus measures
The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients
There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination
From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.